Targeted Medical Pharma, Inc. (TRGM)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Nov 12, 2025

Targeted Medical Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2015FY 2014FY 2013FY 2012FY 2011
Period Ending
Dec '15 Dec '14 Dec '13 Dec '12 Dec '11
Cash & Equivalents
0.080.010.490.330.15
Cash & Short-Term Investments
0.080.010.490.330.15
Cash Growth
604.00%-97.61%50.58%121.63%-85.83%
Accounts Receivable
0.330.20.270.350.9
Other Receivables
0.140.04---
Receivables
0.470.240.270.350.92
Inventory
0.090.130.60.480.5
Prepaid Expenses
0.110.12--1.03
Other Current Assets
0.080.031.271.12-
Total Current Assets
0.830.532.632.532.9
Property, Plant & Equipment
0.050.110.240.340.41
Other Intangible Assets
1.541.862.132.322.39
Long-Term Deferred Tax Assets
---5.413.14
Other Long-Term Assets
---0.030.14
Total Assets
2.432.5510.638.98
Accounts Payable
1.861.461.52.165.04
Accrued Expenses
4.984.613.072.31-
Short-Term Debt
2.52.52.625.032.38
Current Portion of Long-Term Debt
2.121.091.46--
Other Current Liabilities
3.212.682.612.74-
Total Current Liabilities
14.6812.3511.2612.257.48
Long-Term Debt
0.670.120.750.39-
Long-Term Deferred Tax Liabilities
----0.89
Total Liabilities
15.3512.4712.0212.638.37
Common Stock
0.030.030.030.020.02
Additional Paid-In Capital
17.0416.9215.9811.664.68
Retained Earnings
-29.96-26.92-23.02-13.68-4.1
Total Common Equity
-12.9-9.97-7.02-20.61
Minority Interest
-0.02----
Shareholders' Equity
-12.92-9.97-7.02-20.61
Total Liabilities & Equity
2.432.5510.638.98
Total Debt
5.293.724.835.422.38
Net Cash (Debt)
-5.21-3.71-4.34-5.09-2.23
Net Cash Per Share
-0.19-0.14-0.18-0.23-0.10
Filing Date Shares Outstanding
30.1926.7725.7423.0121.95
Total Common Shares Outstanding
27.7326.7725.7423.0121.95
Working Capital
-13.84-11.82-8.63-9.72-4.58
Book Value Per Share
-0.47-0.37-0.27-0.090.03
Tangible Book Value
-14.44-11.83-9.15-4.32-1.78
Tangible Book Value Per Share
-0.52-0.44-0.36-0.19-0.08
Machinery
0.480.830.960.920.83
Leasehold Improvements
0.110.250.250.250.23
Source: S&P Global Market Intelligence. Standard template. Financial Sources.